EQL — EQL Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m
Brief: Eql Pharma Q1 EBIT Loss SEK 13.7 Mln
Brief: EQL Pharma: Mellozzan Approved For Sale In Kazakhstan
Brief: EQL Secures Memprex Licence With Partner For Spain
Brief: EQL Pharma Q4 EBIT SEK 5.1 Mln
Sweden's EQL Pharma Q4 revenue rises
Brief: EQL Pharma CEO Sells SEK 1.2 Million Of Shares In Co
Brief: EQL Pharma Says Mellozzan Has Been Approved In Italy
Brief: EQL Pharma Reports Q3 Sales Up 29% Y/Y
Brief: EQL Pharma Executive Buys SEK 1.0 Million Of Shares In Co
Brief: EQL Pharma Recruits Allan Sylvest Aasberg As New CFO
Brief: EQL Pharma's Methenamine Hippurate Approved In Germany
Brief: Executive Martin Kristofferson Acquired SEK 1.5 Mln Worth Of EQL Pharma Shares
Brief: Eql Pharma Says Sales In Q2 Are Expected To Land Just Under 90 (85.2) MSEK
Brief: EQL Pharma CEO Sells Shares In Co For SEK 23.4 Mln
Brief: EQL Pharma Q1 EBIT Up At SEK 20.5 Mln
Brief: EQL Takes First Step To Establish Itself In Germany And Netherlands
Brief: EQL Pharma Signs Memprex License With Partner For Benelux
Brief: EQL Pharma Q4 EBIT SEK 23 Million
Brief: EQL Pharma Signs Distribution Agreement With Large Distributor